Yi Ban
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 9
- Cancer Cells and Metastasis 4
- Cancer Immunotherapy and Biomarkers 4
- Cytokine Signaling Pathways and Interactions 1
-
- Ubiquitin and proteasome pathways 2
- Cancer therapeutics and mechanisms 2
- Co-authors
- Yi Lisa Lyu (4 shared papers)Leroy F. Liu (4 shared papers)Chao‐Po Lin (3 shared papers)Yuan‐Chin Tsai (1 shared paper)John E. Kerrigan (1 shared paper)Anna M. Azarova (1 shared paper)Xiaojing Ma (6 shared papers)Fang Wei (2 shared papers)
- Journals
- Cancer Research (4 papers)eLife (2 papers)Journal of Biological Chemistry (2 papers)JCI Insight (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesChinaIndia
In The Last Decade
Yi Ban
21 papers receiving 1.7k citations
Yi Ban's Hit Papers
Peers
Comparison fields: 5 of 74
- Cardiology and Cardiovascular Medicine 342
- Oncology 184
- Immunology 119
- Molecular Biology 291
- Nutrition and Dietetics 40
Countries citing papers authored by Yi Ban
This map shows the geographic impact of Yi Ban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Ban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Ban more than expected).
Fields of papers citing papers by Yi Ban
This network shows the impact of papers produced by Yi Ban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Ban. The network helps show where Yi Ban may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Ban, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Topoisomerase IIβ–Mediated DNA Double-Strand Breaks: Implications in Doxorubicin Cardiotoxicity and Prevention by Dexrazoxane Hit paper breakdown → | 2007 | 512 |
| 2 | Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis Hit paper breakdown → | 2021 | 239 |
| 3 | 2015 | 234 | |
| 4 | 2017 | 138 | |
| 5 | 2008 | 102 | |
| 6 | 2023 | 75 | |
| 7 | 2009 | 68 | |
| 8 | 2019 | 64 | |
| 9 | 2016 | 53 | |
| 10 | 2018 | 51 | |
| 11 | 2007 | 47 | |
| 12 | 2021 | 47 | |
| 13 | 2024 | 36 | |
| 14 | 2013 | 26 | |
| 15 | 2018 | 18 | |
| 16 | 2020 | 12 | |
| 17 | 2017 | 11 | |
| 18 | 2023 | 7 | |
| 19 | 2024 | 6 | |
| 20 | 2019 | 4 |
About Yi Ban
Yi Ban is a scholar working on Oncology, Molecular Biology, Nutrition and Dietetics, Pathology and Forensic Medicine and Immunology, having authored 21 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Ubiquitin and proteasome pathways (2 papers), Cancer therapeutics and mechanisms (2 papers), Trace Elements in Health (1 paper), Immune cells in cancer (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Carbohydrate Chemistry and Synthesis (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (342 citations), Oncology (184 citations), Immunology (119 citations), Molecular Biology (291 citations) and Nutrition and Dietetics (40 citations). Yi Ban has collaborated with scholars based in United States, China and India. Frequent co-authors include Yi Lisa Lyu, Leroy F. Liu, Chao‐Po Lin, Yuan‐Chin Tsai, John E. Kerrigan, Anna M. Azarova, Xiaojing Ma, Fang Wei, Lixing Zhang and Hua Zheng. Their work appears in journals such as Cancer Research, eLife, Journal of Biological Chemistry, JCI Insight and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.